EXTREMELY POOR PROGNOSIS OF PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA WITH TRANSLOCATION (9 22) - UPDATED EXPERIENCE

被引:12
作者
FLETCHER, JA
TU, N
TANTRAVAHI, R
SALLAN, SE
机构
[1] Department of Pediatric Oncology and Divisions of Biostatistics and Cytogenetics, Dana-Farber Cancer Institute, Boston, MA
[2] Division of Hematology/Oncology, Children's Hospital, Boston, MA
[3] Department of Pathology, Brigham and Women's Hospital, Boston, MA
[4] Departments of Pediatrics and Pathology, Harvard Medical School, Boston, MA
关键词
ALL; ACUTE LEUKEMIA; POOR PROGNOSIS ALL; T(9 22) PEDIATRIC LEUKEMIA;
D O I
10.3109/10428199209049820
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Approximately five percent of pediatric acute lymphoblastic leukemias (ALL) contain a translocation (9;22)(q34;q11) which results in rearrangement of the bcr and abl genes. At a median follow-up of 5 years, we assessed the prognostic implications of translocation (9;22) in 434 children receiving intensive treatment for ALL. Four-year event-free and overall survivals were only 0% and 20%, respectively, in 15 children with translocation (9;22), but were 81 % and 89%, respectively, in 419 children lacking translocation (9;22) (P < 0.00 1). Based on these findings, we recommend very intensive treatment approaches for all children with translocation (9;22)-positive ALL.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 37 条
[1]  
Williams D.L., Raimondi S., Rivera G., George S., Berard C.W., Murphy S.B., Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia, N. Engl. J. Med., 313, (1985)
[2]  
Pui C.-H., Williams D.L., Raimondi S.C., Et al., Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia, Blood, 70, pp. 247-253, (1987)
[3]  
Williams D.L., Harber J., Murphy S.B., Et al., Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia, Blood, 68, pp. 205-212, (1986)
[4]  
Bloomfield C.D., Goldman A.I., Alimena G., Et al., Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia, Blood, 67, pp. 415-420, (1986)
[5]  
Kalwinsky D.K., Roberson P., Dahl G., Et al., Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia, J. Clin. Oncol, 3, pp. 477-484, (1985)
[6]  
Smets L.A., Slater R.M., Behrendt H., Van't Veer M.B., Homanblok J., Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukemia of childhood, Br. J. Haematol, 61, pp. 113-118, (1985)
[7]  
Fletcher J.A., Kimball V.M., Lynch E., Et al., Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia, Blood, 74, pp. 2130-2135, (1989)
[8]  
Rivera G.K., Raimondi S.C., Hancock M.L., Et al., Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy, Lancet, 337, pp. 61-66, (1991)
[9]  
Rubin C.M., Le Beau M.M., Mick R., Et al., Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia, J. Clin. Oncol, 9, pp. 2183-2192, (1991)
[10]  
Heisterkamp N., Stam K., Groffen J., Structural organization of the bcr gene and its role in the Ph1 translocation, Nature, 315, pp. 758-761, (1985)